Demant

Demant's reported carbon emissions

Demant, a leader in Surgical and Medical Instrument Manufacturing based in Denmark (DK), is committed to reducing its environmental impact. In 2025, the company reported a total of approximately 221.8 million kg CO2e in emissions. This figure is comprised of approximately 15.9 million kg CO2e in Scope 1 emissions and about 10.9 million kg CO2e in Scope 2 emissions (market-based). Scope 3 emissions accounted for the largest portion, totalling approximately 195.0 million kg CO2e. In 2024, Demant's total emissions were approximately 238.7 million kg CO2e, with Scope 1 emissions at about 14.6 million kg CO2e, Scope 2 emissions at approximately 14.8 million kg CO2e (market-based), and Scope 3 emissions at about 209.3 million kg CO2e. Demant has set ambitious climate targets, aiming for a 46.2% reduction in absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 2030, using a 2019 baseline. Similarly, the company targets a 46.2% reduction in absolute Scope 3 GHG emissions by 2030 against the same baseline. These targets align with the Science Based Targets initiative (SBTi) for a 1.5°C pathway. Furthermore, Demant has committed to reaching net-zero GHG emissions across its value chain by 2050, with a long-term goal of reducing absolute Scope 1 and 2 GHG emissions by 90% and Scope 3 GHG emissions by 90% by 2050, also from a 2019 baseline. The company is also committed to reducing absolute Scope 1 GHG emissions by 90% and Scope 2 GHG emissions by 90% by 2050, from a 2019 base year. The data and targets are sourced directly from Demant A/S.